Dallas, TX (PRWEB) September 22, 2013
Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered on chemotherapy. However, the launch of targeted therapies for patients with specific biomarkers has begun to fragment the NSCLC treatment landscape into smaller niche patient populations. Over the forecast period, this trend will continue with the launch of multiple new drugs in several new drug classes to address the high unmet need among NSCLC patients, and provide new treatment options for previously underserved populations. Launch of premium-priced drug candidates combined with increasing incident cases of the disease will be major drivers of growth in the major markets.
This report estimates that branded NSCLC market in China will grow in the forecast period. This increase will be due largely to an increasing aging population; increased use of EGFR and ALK targeted therapies and increased numbers of people covered by private health insurance.
Overview of NSCLC including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
Detailed information on the key drugs in China including product description, safety and efficacy profiles as well as a SWOT analysis.
Sales forecast for the top drugs in China from 2012-2022.
Analysis of the impact of key events as well the drivers and restraints affecting China NSCLC market.
Reasons to Buy
Purchase a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=114312.
Browse more reports on Respiratory Therapeutics Market http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/respiratory-therapeutics.
Contact sales (at) rnrmarketresearch (dot) com for further information.
RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
Read the full story at http://www.prweb.com/releases/china-non-small-cell-lung/drug-market-report/prweb11145242.htm.
Copyright©2012 Vocus, Inc.
All rights reserved